ABBOTT LABORATORIES (ABT)
Clinical trial NCT06241430 updates: 1. completion date: 2027-11-01 → 2030-06-01 2. primary completion date: 2026-11-01 → 2030-06-01 3. collaborators added: National Heart, Lung, and Blood Institute (NHLBI)
Clinical trial NCT06241430 updates: 1. completion date: 2027-11-01 → 2030-06-01 2. primary completion date: 2026-11-01 → 2030-06-01 3. collaborators added: National Heart, Lung, and Blood Institute (NHLBI)
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical